Alzinova in Alzheimer’s News Today
Date: 2021-11-15
"Trial Testing ALZ-101 Alzheimer’s Vaccine Recruits First Patient - The first patient has been recruited, in Finland, for Alzinova AB’s Phase 1b clinical trial testing its ALZ-101 vaccine for Alzheimer’s disease, the company announced."